Frontlight ResearchEarly access
Trial site
The First Affiliated Hospital of Nanchang University Branch Donghu
- 9running trials
- 11closed trials
The trials here
What the 20 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia4 trials
- Lung cancer4 trials
- Diffuse large B-cell lymphoma3 trials
- Follicular lymphoma3 trials
- Mantle cell lymphoma2 trials
- Metastatic breast cancer2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Gastric and oesophageal cancer1 trial
- Head and neck cancer1 trial
- Lupus (SLE)1 trial
- Myelodysplastic syndromes1 trial
- and 2 more
- Phase
- Phase 27 trials
- Phase 36 trials
- Phase 14 trials
- Phase 1/23 trials
- Status
- Completed7 trials
- Active, not recruiting6 trials
- Terminated4 trials
- Recruiting3 trials
- Lead sponsor
- BeiGene13 trials
- BeOne Medicines7 trials
Running trials
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
A Study of BGB-11417 in Participants With Myeloid Malignancies
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Follicular lymphoma1 recruiting
- Mantle cell lymphoma1 recruiting
- Metastatic breast cancer1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
Closed trials
Terminated
Completed
Completed
Completed
Completed
Terminated
A Study of BGB-21447, a Bcl-2 Inhibitor, in Mature B-Cell Malignancies
Terminated
Completed
Completed
Terminated
Completed
Zanubrutinib in Participants With Active Proliferative Lupus Nephritis
Site data: ClinicalTrials.govUpdated 17 Nov 2026